vs
Side-by-side financial comparison of BRINKS CO (BCO) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.1× BRINKS CO). BRINKS CO runs the higher net margin — 4.9% vs -13.6%, a 18.5% gap on every dollar of revenue. On growth, BRINKS CO posted the faster year-over-year revenue change (9.1% vs -5.3%). Over the past eight quarters, BRINKS CO's revenue compounded faster (5.6% CAGR vs -3.6%).
The Brink's Company is an American cash handling company, headquartered in Richmond, Virginia. Its operations include cash-in-transit, ATM replenishment & maintenance, and cash management & payment services, such as vault outsourcing, money processing, intelligent safe services, and international transportation of valuables.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
BCO vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.5B |
| Net Profit | $68.1M | $-205.0M |
| Gross Margin | 27.7% | 49.2% |
| Operating Margin | 13.1% | -9.8% |
| Net Margin | 4.9% | -13.6% |
| Revenue YoY | 9.1% | -5.3% |
| Net Profit YoY | 76.9% | -288.1% |
| EPS (diluted) | $1.62 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $1.5B | ||
| Q3 25 | $1.3B | $1.6B | ||
| Q2 25 | $1.3B | $1.6B | ||
| Q1 25 | $1.2B | $1.5B | ||
| Q4 24 | $1.3B | $1.6B | ||
| Q3 24 | $1.3B | $1.6B | ||
| Q2 24 | $1.3B | $1.6B | ||
| Q1 24 | $1.2B | $1.6B |
| Q4 25 | $68.1M | $-205.0M | ||
| Q3 25 | $36.3M | $160.0M | ||
| Q2 25 | $43.7M | $145.0M | ||
| Q1 25 | $51.6M | $87.0M | ||
| Q4 24 | $38.5M | $109.0M | ||
| Q3 24 | $28.9M | $359.0M | ||
| Q2 24 | $46.2M | $195.0M | ||
| Q1 24 | $49.3M | $201.0M |
| Q4 25 | 27.7% | 49.2% | ||
| Q3 25 | 25.8% | 53.5% | ||
| Q2 25 | 24.9% | 54.8% | ||
| Q1 25 | 24.6% | 55.6% | ||
| Q4 24 | 26.1% | 56.3% | ||
| Q3 24 | 25.0% | 58.3% | ||
| Q2 24 | 25.2% | 58.4% | ||
| Q1 24 | 25.0% | 59.0% |
| Q4 25 | 13.1% | -9.8% | ||
| Q3 25 | 11.4% | 15.2% | ||
| Q2 25 | 10.3% | 14.4% | ||
| Q1 25 | 9.6% | 6.7% | ||
| Q4 24 | 8.3% | 8.1% | ||
| Q3 24 | 8.9% | 13.1% | ||
| Q2 24 | 9.3% | 14.6% | ||
| Q1 24 | 9.8% | 14.5% |
| Q4 25 | 4.9% | -13.6% | ||
| Q3 25 | 2.7% | 10.0% | ||
| Q2 25 | 3.4% | 9.1% | ||
| Q1 25 | 4.1% | 5.8% | ||
| Q4 24 | 3.0% | 6.8% | ||
| Q3 24 | 2.3% | 22.7% | ||
| Q2 24 | 3.7% | 12.1% | ||
| Q1 24 | 4.0% | 12.4% |
| Q4 25 | $1.62 | $-0.78 | ||
| Q3 25 | $0.86 | $0.61 | ||
| Q2 25 | $1.03 | $0.56 | ||
| Q1 25 | $1.18 | $0.33 | ||
| Q4 24 | $0.87 | $0.42 | ||
| Q3 24 | $0.65 | $1.38 | ||
| Q2 24 | $1.02 | $0.75 | ||
| Q1 24 | $1.09 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $574.0M |
| Total DebtLower is stronger | $4.0B | $8.6B |
| Stockholders' EquityBook value | $277.7M | $752.0M |
| Total Assets | $7.3B | $12.9B |
| Debt / EquityLower = less leverage | 14.31× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $574.0M | ||
| Q3 25 | $1.3B | $672.0M | ||
| Q2 25 | $1.4B | $599.0M | ||
| Q1 25 | $1.2B | $547.0M | ||
| Q4 24 | $1.4B | $675.0M | ||
| Q3 24 | $1.2B | $763.0M | ||
| Q2 24 | $1.2B | $704.0M | ||
| Q1 24 | $1.1B | $575.0M |
| Q4 25 | $4.0B | $8.6B | ||
| Q3 25 | $3.8B | $8.8B | ||
| Q2 25 | $3.9B | $8.9B | ||
| Q1 25 | $3.7B | $9.0B | ||
| Q4 24 | $3.7B | $8.9B | ||
| Q3 24 | $3.7B | $8.7B | ||
| Q2 24 | $3.6B | $8.7B | ||
| Q1 24 | $3.4B | $8.7B |
| Q4 25 | $277.7M | $752.0M | ||
| Q3 25 | $268.5M | $906.0M | ||
| Q2 25 | $254.6M | $733.0M | ||
| Q1 25 | $205.8M | $542.0M | ||
| Q4 24 | $184.9M | $472.0M | ||
| Q3 24 | $277.1M | $493.0M | ||
| Q2 24 | $320.5M | $144.0M | ||
| Q1 24 | $396.4M | $48.0M |
| Q4 25 | $7.3B | $12.9B | ||
| Q3 25 | $7.0B | $13.6B | ||
| Q2 25 | $7.1B | $13.5B | ||
| Q1 25 | $6.6B | $13.2B | ||
| Q4 24 | $6.6B | $13.1B | ||
| Q3 24 | $6.7B | $12.8B | ||
| Q2 24 | $6.6B | $12.2B | ||
| Q1 24 | $6.7B | $11.9B |
| Q4 25 | 14.31× | 11.49× | ||
| Q3 25 | 14.05× | 9.74× | ||
| Q2 25 | 15.48× | 12.14× | ||
| Q1 25 | 18.19× | 16.52× | ||
| Q4 24 | 20.26× | 18.81× | ||
| Q3 24 | 13.39× | 17.75× | ||
| Q2 24 | 11.26× | 60.11× | ||
| Q1 24 | 8.67× | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $141.0M |
| Free Cash FlowOCF − Capex | — | $96.0M |
| FCF MarginFCF / Revenue | — | 6.4% |
| Capex IntensityCapex / Revenue | 3.5% | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $141.0M | ||
| Q3 25 | $122.1M | $264.0M | ||
| Q2 25 | — | $220.0M | ||
| Q1 25 | $-60.2M | $75.0M | ||
| Q4 24 | $369.8M | $390.0M | ||
| Q3 24 | $58.4M | $141.0M | ||
| Q2 24 | $-66.1M | $332.0M | ||
| Q1 24 | $63.9M | $76.0M |
| Q4 25 | — | $96.0M | ||
| Q3 25 | $77.4M | $218.0M | ||
| Q2 25 | — | $181.0M | ||
| Q1 25 | $-119.1M | $43.0M | ||
| Q4 24 | $307.2M | $335.0M | ||
| Q3 24 | $7.4M | $99.0M | ||
| Q2 24 | $-122.8M | $300.0M | ||
| Q1 24 | $11.7M | $30.0M |
| Q4 25 | — | 6.4% | ||
| Q3 25 | 5.8% | 13.6% | ||
| Q2 25 | — | 11.4% | ||
| Q1 25 | -9.6% | 2.8% | ||
| Q4 24 | 24.3% | 21.0% | ||
| Q3 24 | 0.6% | 6.3% | ||
| Q2 24 | -9.8% | 18.7% | ||
| Q1 24 | 0.9% | 1.8% |
| Q4 25 | 3.5% | 3.0% | ||
| Q3 25 | 3.3% | 2.9% | ||
| Q2 25 | 4.0% | 2.4% | ||
| Q1 25 | 4.7% | 2.1% | ||
| Q4 24 | 5.0% | 3.5% | ||
| Q3 24 | 4.1% | 2.7% | ||
| Q2 24 | 4.5% | 2.0% | ||
| Q1 24 | 4.2% | 2.8% |
| Q4 25 | — | — | ||
| Q3 25 | 3.36× | 1.65× | ||
| Q2 25 | — | 1.52× | ||
| Q1 25 | -1.17× | 0.86× | ||
| Q4 24 | 9.61× | 3.58× | ||
| Q3 24 | 2.02× | 0.39× | ||
| Q2 24 | -1.43× | 1.70× | ||
| Q1 24 | 1.30× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
